13F
← All fund report cards

Savant Capital, LLC

13F equity value
$20.7B
Positions
1,498
Top 10 concentration
45.4%
Quarters / total new picks
32 / 1,762
13F equity value over time
$0M$10B$21B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.1% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 65.6% of quarters (excess t = 1.62, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.7%
t-stat
1.62
Quarterly win rate
66%
Annualized excess
+2.5%
$1 → follow vs universe
$2.50 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.00120180630: follow 0.98920180930: follow 1.05520181231: follow 1.03720190331: follow 1.04520190630: follow 1.15020190930: follow 1.26620191231: follow 1.11120200331: follow 1.34120200630: follow 1.44820200930: follow 1.57120201231: follow 1.66720210331: follow 1.65020210630: follow 1.84320210930: follow 1.82020211231: follow 1.69120220331: follow 1.65720220630: follow 1.56520220930: follow 1.54720221231: follow 1.49020230331: follow 1.55520230630: follow 1.53720230930: follow 1.76320231231: follow 1.80520240331: follow 1.87920240630: follow 2.08220240930: follow 2.07220241231: follow 1.95420250331: follow 2.14920250630: follow 2.26120250930: follow 2.47220251231: follow 2.499 0.84 1.77 2.70 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 1498 · 2026 Q1

Ticker Value Weight QoQ
AVEM $1.5B
7.3%
ADD
BND $1.2B
6.0%
ADD
AVDV $1.2B
5.6%
HOLD
DIHP $937M
4.5%
ADD
BNDX $868M
4.2%
ADD
VTI $833M
4.0%
ADD
DFUV $746M
3.6%
TRIM
DFLV $736M
3.6%
ADD
JQUA $700M
3.4%
ADD
DFSV $661M
3.2%
ADD
DFAC $481M
2.3%
ADD
DFIV $462M
2.2%
HOLD
VGIT $354M
1.7%
ADD
DFGR $339M
1.6%
ADD
DFAT $299M
1.4%
HOLD
JPIE $296M
1.4%
ADD
IDEV $275M
1.3%
ADD
VEA $244M
1.2%
ADD
AAPL $202M
1.0%
ADD
DFSD $187M
0.9%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.